Home » Stocks » AGTC

Applied Genetic Technologies Corporation (AGTC)

Stock Price: $3.60 USD -0.05 (-1.37%)
Updated Jul 30, 2021 4:00 PM EDT - Market closed
After-hours: $3.65 +0.05 (1.39%) Jul 30, 6:11 PM
Market Cap 153.92M
Revenue (ttm) n/a
Net Income (ttm) -60.20M
Shares Out 36.75M
EPS (ttm) -2.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 30
Last Price $3.60
Previous Close $3.65
Change ($) -0.05
Change (%) -1.37%
Day's Open 3.65
Day's Range 3.58 - 3.69
Day's Volume 551,196
52-Week Range 3.47 - 9.67

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

- Activities to support the next stage of clinical development of ACHM B3 candidate are ongoing-

1 month ago - GlobeNewsWire

GAINESVILLE, Fla. and CAMBRIDGE, Mass., June 23, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-assoc...

1 month ago - GlobeNewsWire

-AGTC patient advocacy executive director will highlight the state of gene therapy  trial recruitment for IRDs-

1 month ago - GlobeNewsWire

Investors need to pay close attention to Applied Genetic Technologies (AGTC) stock based on the movements in the options market lately.

1 month ago - Zacks Investment Research

Penny stocks are not usually on lists of must-buy stocks, but that does not mean these companies cannot explode in the coming weeks. The post 7 Penny Stocks To Watch Before They Pop Due to Reddit Users ...

Other stocks mentioned: GNUS, GSAT, IDEX, NAKD, NOK, ZOM
1 month ago - InvestorPlace

- Reported 50% response rate in visual sensitivity among patients in highest dose groups in ongoing Phase 1/2 clinical trial of its XLRP gene therapy candidate for patients who met inclusion criteria fo...

2 months ago - GlobeNewsWire

GAINESVILLE, Fla., May 14, 2021 /PRNewswire/ -- Concept Companies, a Gainesville headquartered full-service real estate development and construction firm, has executed an agreement to commence developme...

2 months ago - PRNewsWire

InvestorPlace is closing out a busy week of trading with a look at the Reddit penny stocks seeing the most chatter on Friday. The post 5 Reddit Penny Stocks Seeing the Most Chatter Friday appeared first...

Other stocks mentioned: ATOS, CLOV, CTXR, SENS
2 months ago - InvestorPlace

- Company plans to lease 21,000 square foot build-to-suit cGMP manufacturing facility adjacent to its Florida facility -

2 months ago - GlobeNewsWire

It's time to take another look at penny stocks that are popular on Reddit as we dive into those getting the most attention on Thursday. The post 5 Reddit Penny Stocks Seeing the Most Chatter Thursday ap...

Other stocks mentioned: AMC, PRPO, RIOT, SOS
2 months ago - InvestorPlace

Applied Genetic Technologies Corporation (NASDAQ: AGTC) has announced additional data from the ongoing X-linked retinitis pigmentosa (XLRP) gene therapy Phase 1/2 trial, including 12-month data from Gro...

2 months ago - Benzinga

-Groups 5 and 6 had a 50% response rate among patients who met the inclusion criteria for the Skyline and Vista trials-

2 months ago - GlobeNewsWire

GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associ...

2 months ago - GlobeNewsWire

GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associ...

2 months ago - GlobeNewsWire

-Company remains on track to present additional 12-month data from the XLRP and achromatopsia clinical trials in the second quarter of 2021-

2 months ago - GlobeNewsWire

GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-asso...

3 months ago - GlobeNewsWire

GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-asso...

3 months ago - GlobeNewsWire

- AGTC Transfers Clinical Trial Materials and Phase 1/2 Data To TeamedON -

3 months ago - GlobeNewsWire

GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-asso...

4 months ago - GlobeNewsWire

-AGTC's deep commitment to the patient voice drives solutions to support patient access to information and to improve the experience of patients participating in clinical trials-

4 months ago - GlobeNewsWire

-AGTC will highlight the value of the patient voice in gene therapy development-

4 months ago - GlobeNewsWire

Getting a big headache watching large-cap S&P 500 stocks lose steam? Small-cap stocks are giving investors a new way to make big money.

Other stocks mentioned: ATOM, AYTU, CODX, CRTX, DVAX, SRNE
4 months ago - Investors Business Daily

GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-asso...

4 months ago - GlobeNewsWire

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-assoc...

5 months ago - GlobeNewsWire

-AGTC executives will address critical success factors in gene therapy manufacturing and the value of the patient perspective in gene therapy development ---- GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb...

5 months ago - GlobeNewsWire

- Company on track to provide multiple data readouts for XLRP and ACHM clinical programs in 2021 and 2022 -

5 months ago - GlobeNewsWire

Article reflects Company's leadership and innovation in scalable, reproducible manufacture of adeno-associated virus (AAV)-based gene therapies

5 months ago - GlobeNewsWire

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-assoc...

5 months ago - GlobeNewsWire

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-asso...

6 months ago - GlobeNewsWire

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-asso...

6 months ago - GlobeNewsWire

-Preliminary results suggest sustained improvements to 12-months in visual sensitivity, as measured by full field static perimetry, supported in some patients by other endpoints- -Company plans longer t...

6 months ago - GlobeNewsWire

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company focused on developing adeno-associated virus (A...

6 months ago - GlobeNewsWire

Applied Genetic Technologies (AGTC) delivered earnings and revenue surprises of -17.65% and -100.00%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for...

8 months ago - Zacks Investment Research

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-assoc...

8 months ago - GlobeNewsWire

- Durable improvements observed in visual sensitivity and visual acuity over a wide dose-range with a favorable safety profile -

8 months ago - GlobeNewsWire

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-assoc...

8 months ago - GlobeNewsWire

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company focused on developing adeno-associated virus (...

9 months ago - GlobeNewsWire

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 08, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company focused on developing adeno-associated virus (A...

9 months ago - GlobeNewsWire

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (AGTC), Blueprint Genetics, and Foundation Fighting Blindness, announce today that AGT...

9 months ago - GlobeNewsWire

Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q4 2020 Results - Earnings Call Transcript

10 months ago - Seeking Alpha

- Planned Phase 2/3 trial expected to include approximately 60 patients and a responder analysis based on at least 7 decibel improvement in visual sensitivity in at least 5 loci across two active dose g...

10 months ago - GlobeNewsWire

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company focused on developing adeno-associated viru...

10 months ago - GlobeNewsWire

Preclinical studies validate the transgene and dosing used in the ongoing Phase 1/2 clinical trial in patients with XLRP due to mutations in the RPGR gene Preclinical studies validate the transgene and ...

11 months ago - GlobeNewsWire

Patient Advisory Council to include advocates from the inherited retinal diseases global community

11 months ago - GlobeNewsWire

Washington D.C--(Newsfile Corp. - August 4, 2020) - At today’s meeting of the Small Business Capital Formation Advisory Committee, the Securities and Exchange Commission announced the appointment of two...

11 months ago - Newsfile Corp

Does Applied Genetic Technologies (AGTC) have what it takes to be a top stock pick for momentum investors? Let's find out.

1 year ago - Zacks Investment Research

Is (AGTC) Outperforming Other Medical Stocks This Year?

1 year ago - Zacks Investment Research

Applied Genetic (AGTC) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

1 year ago - Zacks Investment Research

GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 24, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-as...

1 year ago - GlobeNewsWire

About AGTC

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's advanced product candidates consist of three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which has completed Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate for the patients with advanced retinal disease. I... [Read more...]

Industry
Biotechnology
IPO Date
Mar 27, 2014
CEO
Susan Washer
Employees
83
Stock Exchange
NASDAQ
Ticker Symbol
AGTC
Full Company Profile

Financial Performance

In 2020, AGTC's revenue was $2.45 million, a decrease of -94.12% compared to the previous year's $41.69 million. Losses were -$45.89 million, 2,187.7% more than in 2019.

Financial Statements

Analyst Forecasts

According to 8 analysts, the average rating for AGTC stock is "Strong Buy." The 12-month stock price forecast is 15.78, which is an increase of 338.33% from the latest price.

Price Target
$15.78
(338.33% upside)
Analyst Consensus: Strong Buy